Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Estrogen in Pelvic Organ Prolapse
NCT01886794Phase 4Terminated
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Jun 2013
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of estradiol topical in pelvic organ prolapse (POP) (3 arms), sponsored by The University of Texas Medical Branch at Galveston. Primary endpoint: Vaginal Epithelial Thickness at 1 month. Started Jun 2013; status: terminated.
02
Drugs
estradiol topical
03
Conditions
pelvic organ prolapse (POP)
Beyond the preview
Go deeper on NCT01886794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01886794.